Advertisement National Stem Cell Holding to change name to Proteonomix - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

National Stem Cell Holding to change name to Proteonomix

National Stem Cell Holding has announced that it is taking steps to change its name to Proteonomix. The change will also entail a change in its trading symbol.

Further, the company also intends to begin marketing its current portfolio biomarkers to research laboratories globally.

Michael Cohen, president and CEO of National Stem Cell Holding, said: “Our new name reflects the fact that we are emerging out of our R&D stage and commencing the commercialization of our technologies. These technologies relate in great part to the identification of proteins, and their structure and functions within the emerging biotherapeutics field.”